How would you like to read? Click one below.
At any time, click this 
to change word size.
Disclaimer
By selecting this link, you will be leaving www.LUCENTIS.com and going to a site that is not controlled by or affiliated with Genentech USA, Inc. Genentech is neither affiliated with nor endorses any of the aforementioned organizations. The information provided by Genentech or these organizations is meant for informational purposes only and is not meant to replace your doctor's medical advice.
Disclaimer
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD).
What important safety information should I know about LUCENTIS?
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.
Some patients have had increased eye pressure before and within 1 hour of an injection.
Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse.
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, joint pain, and lung/airway infections.
If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
MACULAR DEGENERATION
Results With LUCENTIS
Click on a tab below to learn more about results with LUCENTIS.
In one 2-year clinical study, 9 out of 10 people receiving LUCENTIS monthly maintained* or improved their vision.
*Defined as losing fewer than 15 letters on the eye chart.
LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. Please see additional important safety information below.
Remember, if your vision stays the same or improves, it may mean that you can keep doing many of the simple things that are most important to you.
In clinical studies, a full 2 years after starting treatment, people who received LUCENTIS once a month were able to read 21 more letters on the eye chart, on average, than people who received placebo.
For example, a person with untreated wet AMD may only be able to read a few letters on the eye chart.
In a clinical study, patients who received LUCENTIS monthly were able to read, on average, 21 additional letters on the eye chart compared with people who received placebo.
Serious side effects include inflammation inside the eye, and rarely, problems related to the injection procedure, such as developing a cataract. These can make your vision worse. Please see additional important safety information below.
In clinical studies, up to 4 out of 10 patients saw their visual acuity improve to 20/40 or better after 2 years of monthly LUCENTIS compared with fewer than 1 out of 10 patients treated with placebo.
What does visual acuity mean?
Visual acuity (VA) is the ability to see fine detail clearly. For example:
The most common side effects to your eye are increased redness in the whites of your eye, eye pain, small specks in vision, and the feeling that something is in your eye. The most common non–eye-related side effects are nose and throat infections, headache, and respiratory (lung) infections. Please see additional important safety information below.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD).
What important safety information should I know about LUCENTIS?
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.
Some patients have had increased eye pressure before and within 1 hour of an injection.
Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse.
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, joint pain, and lung/airway infections.
If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
This site is intended for US residents only.
